CN111467414A - 一种治疗新冠状病毒的中药组合物及制备方法 - Google Patents
一种治疗新冠状病毒的中药组合物及制备方法 Download PDFInfo
- Publication number
- CN111467414A CN111467414A CN202010096544.8A CN202010096544A CN111467414A CN 111467414 A CN111467414 A CN 111467414A CN 202010096544 A CN202010096544 A CN 202010096544A CN 111467414 A CN111467414 A CN 111467414A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- traditional chinese
- chinese medicine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 59
- 239000000843 powder Substances 0.000 claims abstract description 17
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 9
- 239000010440 gypsum Substances 0.000 claims abstract description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 8
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 8
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 8
- 241000245050 Menispermum Species 0.000 claims abstract description 8
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 241000759909 Camptotheca Species 0.000 claims abstract description 7
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 7
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 7
- 241000334160 Isatis Species 0.000 claims abstract description 6
- 240000004980 Rheum officinale Species 0.000 claims abstract description 4
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 241001164374 Calyx Species 0.000 claims abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 claims abstract 3
- 238000002156 mixing Methods 0.000 claims description 6
- 240000008027 Akebia quinata Species 0.000 claims description 5
- 235000007756 Akebia quinata Nutrition 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 241001465382 Physalis alkekengi Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 16
- 238000011282 treatment Methods 0.000 abstract description 15
- 230000009385 viral infection Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 description 16
- 238000011049 filling Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 208000001528 Coronaviridae Infections Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 241000219061 Rheum Species 0.000 description 4
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 210000004233 talus Anatomy 0.000 description 4
- 241000700605 Viruses Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000576429 Forsythia suspensa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000010231 banlangen Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000701386 African swine fever virus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000759905 Camptotheca acuminata Species 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000737253 Lygodium japonicum Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗新冠状病毒的中药组合物及制备方法,属于医疗领域。本中药组合物以天然中药为原料,药物组成及配比为:五叶藤2—5份,洛神珠(别名酸浆)2—5份,连翘2—5份,喜树果2—5份,北豆根1—2份,蒲公英2—5份,大黄2—5份,板蓝根2—5份,黄芪2—5份,牡丹皮2—5份,生石膏1—3份,炙甘草2—5份。本发明的制备方法主要有两种。可将各组分粉碎为超细粉,灌入胶囊制备成胶囊制剂,也可以将各组分粉碎成粗粉熬制成汤剂。但不限于这两种制备方法。本发明理论上对于多种病毒感染均有治疗效果。
Description
技术领域
本发明涉及一种治疗新冠状病毒感染的治疗方法,属于医疗领域。
背景技术
新冠状病毒疫情爆发以来,造成了人民生命和社会资源的巨大损失。实际上,人类和病毒疫情的斗争从来就没有间断过。很明显,研发出有效的抗新冠病毒药物或治疗方法,是阻击病毒疫情的最终方式。
本次疫情的阻击战中,中医药的治疗方法,发挥了极大优势。事实上,我国传统中医药的广阔发展前景,当前已经被国际社会广泛认可和重视。因此,应用中医药理论及方法治疗新冠病毒感染,应成为广大科技工作者的工作重点。
本次新冠病毒感染的治疗过程中,已经采用的传统中医药方法,虽然有疗效,但不足之处也暴露的很明显。
首先,传统方法是以汤剂为主。汤剂是使用比较广泛的剂型,也是中医药领域最常用的制剂方案。但汤剂加工和服用不是很方便,无法常温保存太久,而冷服则影响效力。同时,汤剂进行产品化的难度也较高。因此,汤剂不太适合大规模产品化来进行广泛应用。
其次,传统方法需要辩证论治,,此法效率较低,而且需要大量专业中医人才,应对疫情快速扩散的情况,力不从心。
最后,传统方法起效较慢,对于中、重患者,不利于治疗。
因此,开发出服用方便、储存期长、治疗方案标准化、无需专业人才实施、起效快、标本兼治、成本低廉的新型中药组合物,是本发明要实现的研发目标。
发明人及所带团队依托中成药研发经验,在继承和发扬传统中医药理论的基础上,创新用药,发明出了治疗新冠状病毒的中药组合物,并确定了制备方法。
发明内容
本发明提供了一种治疗新冠状病毒感染的中药组合物及制备方法。
发明人经仔细研究后发现,针对本次疫情,传统的“主要针对肺部”入药的思路,不会十分理想。因为病毒类感染,是经口鼻进入体内的外邪,患者的诸多症状,不仅由肺部引起,同样重要的因素,乃是外邪入侵引发经络淤阻,同时外邪之毒不能外泄,致使人体同步出现发热等症状,不得已,部分患者的机体必然采取肠胃不畅、腹泻等反应以利于排毒,但自然反应已经不足以清除外邪。
因此,发明人认为,用药之法,除针对肺经,同步也要针对连带经络进行综合调理,这就是为什么本方用药,归经较多的原因。除肺经,本方归经还侧重于大肠经、胆经等,采取泄毒为辅的方法,“疏通”和“排污”同步进行,起效迅速,机体恢复速度也快,免疫力恢复迅速,综合治疗效果更佳。
基于以上分析,发明人在用药品种方面,创新使用五叶藤、洛神珠、喜树果作为主药。虽然以上品种不属于抗病毒常用药,但其解毒、散结、利水、抗菌等疗效,是值得肯定和公认的。本次将以上品种作为主药,创新使用的效果很理想。同时,辅以板蓝根、蒲公英、、连翘、大黄作为辅药,不仅强化了主药的作用,而且此等品种抗病毒等效果是成熟且公认的,借鉴了验方的成熟经验,降低了用药风险。组合物中,将黄芪、牡丹皮、北豆根作为进一步辅助,不仅提气血,而且可以排毒消炎。此外,本团队大胆使用了生石膏作为进一步辅助,极少量口服,起到了凉血等作用。最后,使用甘草调和诸药。
以上不难看出,本方用药是针对以往成方和经验的突破,在抗病毒中成药中,使用五叶藤等品种更是首创。
本中药组合物中的所有用药,无毒性品种,无特别冷背品种,无配伍禁忌。而且所有品种均为天然植物药,品种较常见,来源广泛,成本较低廉。
发明人及团队,经大量筛选及实践,确定了由12味中药组成的中药组合物。本发明的中药组合物,主要以天然中药为原料。本发明引入的计量概念是“份”。“份”的概念,在本专利中是1个基本质量衡量单位,如1克、1两、1公斤等。
本组合物的药物组成及配比为:
五叶藤 2—5份
洛神珠(别名酸浆) 2—5份
连翘 2—5份
喜树果 2—5份
北豆根 1—2份
蒲公英 2—5份
大黄 2—5份
板蓝根 2—5份
黄芪 2—5份
牡丹皮 2—5份
生石膏 1—3份
炙甘草 2—5份。
本中药组合物优选配比:
五叶藤 3份
洛神珠(别名酸浆) 3份
连翘 3份
喜树果 3份
北豆根 1份
蒲公英 3份
大黄 3份
板蓝根 3份
黄芪 3份
牡丹皮 3份
生石膏 1.5份
炙甘草 2份。
本中药组合物,其制备方式主要有两种,但不限于两种。
一种是制备成胶囊制剂。
将各成分分别粉碎,过200目筛,制成超细粉。超细粉的药物吸收率,要比粗粉高。然后将各成分超细粉按配比加入药粉混合机,混匀后灌装胶囊。本发明采用0号或1号胶囊,每粒药粉含量约为0.65g。
服用方法1)初发阶段的轻症患者:每日服3次,每次服6粒,温开水服下。
2) 中、重症患者:每日服6-9次,每次服6粒,温开水服下。
服药后,应多喝温开水,以促进药物吸收。
服药禁忌:忌酒、辛辣、油腻。孕妇酌情,8岁以下小儿减为每次两粒胶囊。
另一种是制备成汤剂。
将各成分分别粉碎,过5-10目筛,粉碎成粗粉。然后将各成分粗粉按配比混合,装入茶叶袋。每袋为一剂,每剂约10g。熬制时,将一剂放入砂锅中或搪瓷锅中,注意不要用金属器皿,倒入1000ml纯净水,浸泡半小时,大火烧开后小火慢熬,至约300ml左右,关火,倒出药液,温热喝下。
服用方法:1)初发阶段的轻症患者:每日服3次,每次服1剂。
2)中、重症患者:每日服6剂。
服药禁忌:忌酒、辛辣、油腻。孕妇酌情,8岁以下小儿减为每次两剂。
当然,本发明的制备方式将不限于上述两种。
本发明由于归经准确,用药创新,因此,其治疗效果也突破了传统指标。
1)起效迅速:服药后,当天或第二天即可起效,发烧、腹泻等症状明显改善,患者体征基本稳定。
2) 标本兼治:除可以对抗病毒感染外,本药还有排毒、增气血、迅速提高机体自身免疫力等复合的功能,在治疗疾病本身的同时,同步进行机体康复。
3) 无需辩证论治,适应范围广,基层实施容易:只要确诊是冠状病毒或病毒类病因,即可用药。治疗方法标准。
4)成本低廉:本药继承发扬了传统中药物美价廉的优势,有望成为普及型抗病毒药物。为全社会极大降低成本,减轻民众负担。
5)易于大规模生产,可快速进行疫区投放:本药采用原药磨粉、按成方混匀、直接灌装胶囊的生产方式,生产工艺简单,质控容易,易于短期内大规模生产投放。
6)除新冠病毒外,本发明理论上对多种病毒感染也有治疗效果:如HIV病毒、非洲猪瘟病毒、埃博拉病毒、感冒病毒等。但其他病毒感染的治疗效果,发明人尚未尝试。
本发明实验结果
(1)体外实验:将本发明的胶囊制剂,取3粒的内容物,约1.8g药粉,加入10ml 37℃纯净水中 ,恒温搅拌5分钟,模拟胃内蠕动分散过程。然后取浸出液,做新冠病毒株体外杀灭试验。
结果:
本发明的浸出液,可在5分钟内将96%病毒株全部杀灭。10分钟后,杀灭率100%。
结论:
本发明的胶囊制剂,对直接清除新冠病毒有效。
(2)白鼠实验:选取接种新冠病毒的小白鼠10只,平均体重12.5g。
取将本发明的胶囊制剂,取0.5粒的内容物,约0.3g药粉,加入1ml纯净水,搅拌均匀,直接用针筒灌食。每日3次。
结果:
28小时后,8只症状消失,32小时后,剩余2只中的1只症状消失,40小时后,剩余1只症状也消失。检测后,冠状病毒检出结果均为阴性。解剖结果显示,小鼠肺部除新增钙化点外,未见病毒大面积感染迹象。
结论:
本发明的中药组合物,体内服用,对新冠病毒感染治疗明显,可以做到短期内治愈。
实施例
1)胶囊制剂制备方法
胶囊制剂组方配比为:
五叶藤 30kg,连翘 30kg,洛神珠30kg,喜树果30kg,北豆根 10kg,蒲公英 30kg,大黄30kg,板蓝根30kg,黄芪30kg,牡丹皮30kg,炙甘草30kg,生石膏15kg
先将各组分用电动中草药粉碎机粉碎,过200目筛,制成超细粉。按上述配比取各组分,向电动药粉料混合机混匀。制成约325kg药粉。将混匀后的药粉加入全自动胶囊灌装机中,使用0号胶囊,每粒灌装量设定为0.6g,扣除原料损耗,可至少灌装54万粒成品胶囊。
2)汤剂制备方法
汤剂组方配比为:
五叶藤 30g,连翘 30g,洛神珠30g,喜树果30g,北豆根 10g,蒲公英 30g,大黄30g,板蓝根30g,黄芪30g,牡丹皮30g,炙甘草20g,生石膏15g
先将各组分用药钵捣碎,粒径约3-5mm。按上述配比取各组分,在5L塑料烧杯中混匀,制成约325g中药混合物。按每袋约10g装量,装入10cm×10cm茶叶袋,封口。每袋为一剂。制成约30剂。在2L容量的中药陶罐中加入500ml纯净水,每次取1剂,放入水中浸泡30-40分钟。然后大火烧开,小火慢熬,直至液体量减至约一半。关火,倒出药液,晾温热后,一次性喝下。切记不要冷服,汤剂也不要过夜。
Claims (4)
1.一种治疗新冠状病毒的中药组合物及制备方法,其特征在于,药物组成及配比为:五叶藤2—5份,洛神珠(别名酸浆)2—5份,连翘2—5份,喜树果2—5份,北豆根1—2份,蒲公英2—5份,大黄2—5份,板蓝根2—5份,黄芪2—5份,牡丹皮2—5份,生石膏1—3份,炙甘草2—5份。
2.如权利要求1中所述的中药组合物及制备方法,其特征在于,药物组成及配比为:五叶藤3份,洛神珠(别名酸浆)3份,连翘3份,喜树果3份,北豆根1份,蒲公英3份,大黄3份,板蓝根3份,黄芪3份,牡丹皮3份,生石膏1.5份,炙甘草2份。
3.如权利要求1中所述的中药组合物及制备方法,其特征在于,制备方法可以是将各组分制成超细粉,混合后灌成胶囊制剂。
4.如权利要求1中所述的中药组合物及制备方法,其特征在于,制备方法可以是将各组分制成粗粉,混合后熬制成汤剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010096544.8A CN111467414A (zh) | 2020-02-18 | 2020-02-18 | 一种治疗新冠状病毒的中药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010096544.8A CN111467414A (zh) | 2020-02-18 | 2020-02-18 | 一种治疗新冠状病毒的中药组合物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111467414A true CN111467414A (zh) | 2020-07-31 |
Family
ID=71747170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010096544.8A Pending CN111467414A (zh) | 2020-02-18 | 2020-02-18 | 一种治疗新冠状病毒的中药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111467414A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022043738A1 (es) * | 2020-08-29 | 2022-03-03 | Portillo Rosado Rosa Maria | Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211997A (zh) * | 2013-05-13 | 2013-07-24 | 刘健享 | 一种抗菌抗病毒的中药组合物法及其制备方法 |
CN104906542A (zh) * | 2015-06-12 | 2015-09-16 | 天农大(天津)生物科技有限公司 | 一种治疗犬冠状病毒感染的中药组合物及其制备方法 |
CN105079226A (zh) * | 2014-05-22 | 2015-11-25 | 北京以岭药业有限公司 | 一种中药组合物在制备抗中东新型冠状病毒药物中的应用 |
-
2020
- 2020-02-18 CN CN202010096544.8A patent/CN111467414A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211997A (zh) * | 2013-05-13 | 2013-07-24 | 刘健享 | 一种抗菌抗病毒的中药组合物法及其制备方法 |
CN105079226A (zh) * | 2014-05-22 | 2015-11-25 | 北京以岭药业有限公司 | 一种中药组合物在制备抗中东新型冠状病毒药物中的应用 |
CN104906542A (zh) * | 2015-06-12 | 2015-09-16 | 天农大(天津)生物科技有限公司 | 一种治疗犬冠状病毒感染的中药组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022043738A1 (es) * | 2020-08-29 | 2022-03-03 | Portillo Rosado Rosa Maria | Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526671B (zh) | 一种预防治疗咳嗽感冒的中药组合物及其配制方法 | |
CN104922543A (zh) | 一种治疗闭经的药物组合物及其制备方法 | |
CN100478020C (zh) | 治疗口腔溃疡的药物 | |
CN105031035A (zh) | 一种治疗鼻炎的药物及其制备方法 | |
CN103127326A (zh) | 一种治疗骨关节炎的药物组合物及其制备方法 | |
CN107243022A (zh) | 治疗癌症的中药蜜丸及其制备方法 | |
CN111467414A (zh) | 一种治疗新冠状病毒的中药组合物及制备方法 | |
CN102134543A (zh) | 一种具有调理脾胃功效的药酒 | |
CN102106999B (zh) | 一种治疗中风病后吞咽困难的中药复方制剂及其制备方法 | |
CN102600387A (zh) | 一种治疗急性病毒性心肌炎并发肠毒症的中草药制剂 | |
CN1593566A (zh) | 偏瘫康复丸 | |
CN101843829B (zh) | 一种治疗肺心病的中药 | |
CN101336976A (zh) | 一种治疗生殖器疱疹的内服中药的配方及其制备方法 | |
CN109771632A (zh) | 一种治疗慢性阻塞性肺疾病稳定期的药物组合物及其制备方法和用途 | |
CN103006950A (zh) | 一种治疗咽喉炎的中药及其制备工艺 | |
CN102488807A (zh) | 一种治疗哮喘的药物 | |
CN101829213B (zh) | 治疗哮喘的药物组合物及其制备方法 | |
CN101843877B (zh) | 一种治疗肝硬化的中药 | |
CN106362008A (zh) | 一种治疗风湿疼痛的药物及其制备方法 | |
CN103920132A (zh) | 一种治疗身体阳虚的药物及其制备方法 | |
CN103223025A (zh) | 一种治疗胃炎的药物及其制备方法 | |
CN103860632A (zh) | 一种治疗脚气的药物及其制备方法 | |
CN1403127A (zh) | 一种治疗甲亢的龙珠平亢药物及制备方法 | |
CN117018131A (zh) | 一种用于治疗持续性hpv感染的中药组合物及其制备方法 | |
CN113209221A (zh) | 一种中药补肾胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200731 |